Use of the Building Resilience Against Climate Effects (BRACE) Framework to Project Climate-Related Disease Burden
Step two of the five-step BRACE framework focuses on projecting disease burden. Assessing the projected health burden of climate change is an important step for public health agencies to prepare for these impacts. Disease burden projection is a complex process, and involves assessing causal pathways, assembling baseline climate and disease burden, choosing indicators, developing or utilizing an exposure-response function, and evaluating uncertainty. This can be done qualitatively or quantitatively. While quantitative projections provide more useful information about likely impacts, many health departments are not particularly familiar with scenario-based, quantitative disease projections. As part of BRACE, health agencies are able to produce estimates of the future burden of disease for climate-related health outcomes. This information can then be used to rank the health outcomes, prioritize preventive actions, and design health adaptation plans.
This presentation will give an overview of step two of the BRACE framework, describe CDC’s guidance on projecting climate-related disease burden, and give examples of implementation and best practices from CRSCI health department grantees.
Learning Areas:Environmental health sciences
Describe methods for projecting climate-related disease burden. Identify steps CDC’s Climate and Health Program is taking to support health departments to project climate-related disease burden.
Keyword(s): Climate and Health, Environmental Health
Qualified on the content I am responsible for because: I am a health scientist in CDC's Climate and Health Program. Among my principle activities is support of the BRACE framework, including participation in development and improvement of the framework. I coordinate technical assistance from CDC to state health departments in their implementation of BRACE.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.